{"disease":{"id":"high-bleeding-risk","name":"high bleeding risk"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07383155","title":"Bivalirudin Versus Heparin During PCI in High Bleeding Risk Patients With Acute Coronary Syndromes","phase":"PHASE4","overall_status":"NOT_YET_RECRUITING","enrollment_count":5270,"lead_sponsor_name":"Shenyang Northern Hospital","has_results":false},{"nct_id":"NCT03023020","title":"Management of High Bleeding Risk Patients Post Bioresorbable Polymer Coated Stent Implantation With an Abbreviated Versus Prolonged DAPT Regimen","phase":"NA","overall_status":"COMPLETED","enrollment_count":4579,"lead_sponsor_name":"ECRI bv","has_results":false},{"nct_id":"NCT07354828","title":"Optimization and Validation of Quality Control Indicators for Coronary Revascularization Based on Antiplatelet Therapy","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":3500,"lead_sponsor_name":"Shenyang Northern Hospital","has_results":false},{"nct_id":"NCT06763744","title":"Genotype-Guided Abbreviated DAPT Versus Un-Guided De-escalation Therapy in Patients With ACS and HBR","phase":"PHASE4","overall_status":"NOT_YET_RECRUITING","enrollment_count":3000,"lead_sponsor_name":"Samsung Medical Center","has_results":false},{"nct_id":"NCT04500912","title":"Comparison of the Supraflex Cruz 60 Micron Versus the Ultimaster Tansei 80 Micron in HBR PCI Population","phase":"NA","overall_status":"COMPLETED","enrollment_count":736,"lead_sponsor_name":"Pieter C.Smits","has_results":false},{"nct_id":"NCT06535568","title":"Single vs. Dual Antiplatelet Therapy in Elderly or HBR Patients Undergoing Percutaneous Intervention With DCB (PICCOLETO IV-EPIC 38)","phase":"NA","overall_status":"RECRUITING","enrollment_count":576,"lead_sponsor_name":"Fondazione Ricerca e Innovazione Cardiovascolare ETS","has_results":false},{"nct_id":"NCT07125417","title":"Non-antithrombotic Versus. Single Antiplatelet Therapy Following Left Atrial Appendage Closure","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":500,"lead_sponsor_name":"OCEAN-SHD Study Group","has_results":false},{"nct_id":"NCT07374718","title":"Safety and Efficacy of De-escalation Dual Antiplatelet Therapy After BioFreedom™ Stenting in ACS Patients With Moderate-to-high Ischemic and High Bleeding Risk","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":468,"lead_sponsor_name":"Shenyang Northern Hospital","has_results":false},{"nct_id":"NCT05240781","title":"Zotarolimus vs Sirolimus Eluting Stent in High Bleeding Risk","phase":"NA","overall_status":"UNKNOWN","enrollment_count":280,"lead_sponsor_name":"Instituto Nacional de Cardiologia Ignacio Chavez","has_results":false},{"nct_id":"NCT05643430","title":"ULTRA LONG: BioFreedom Ultra","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":86,"lead_sponsor_name":"Biosensors Europe SA","has_results":false},{"nct_id":"NCT07238764","title":"OCT-based DAPT Cessation in HBR Patients","phase":"NA","overall_status":"COMPLETED","enrollment_count":40,"lead_sponsor_name":"Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health","has_results":false},{"nct_id":"NCT04885816","title":"Drug-eluting Balloon Versus Drug-eluting Stent for High Bleeding Risk Angioplasty","phase":"NA","overall_status":"TERMINATED","enrollment_count":5,"lead_sponsor_name":"Instituto Nacional de Cardiologia Ignacio Chavez","has_results":false}],"total":12},"guidelines":[],"source":"Drug Landscape verified database"}